COLLEEN CRAWFORD: Open Payments
NPI 1831354109 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 25 payments from 9 companies in 2025. Trend: 2023 $112 · 2024 $0 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $191 |
| Madrigal Pharmaceuticals | 3 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Ardelyx, Inc. | 2 | $47 |
| Janssen Biotech, Inc. | 2 | $42 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $17 |
| Amgen Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 2 | $14 |
Products named: REZDIFFRA, RINVOQ, CREON, MAVYRET, IBSRELA, ENTYVIO, TREMFYA, ZENPEP.
Industry payments across FL — which companies pay providers there.
